% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • frogsleapmerlot frogsleapmerlot Nov 7, 2006 4:21 PM Flag

    Year-End Book Value is $7 Bucks

    So at $10 we are only paying $120M for the pipeline, GNRH is potential $500M to $1B Drug depending on longterm 6 Month P2 Bone Density Trial, Get results early summer FY07.Positive results and NBIX is back trading High Teens.

50.82+1.20(+2.42%)Jul 27 4:00 PMEDT